# Myfembree

NDC: 72974-415
Generic name: relugolix, estradiol hemihydrate, and norethindrone acetate
Labeler / Manufacturer: Sumitomo Pharma America, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20210526

FDA application: NDA214846

## Active ingredients

- ESTRADIOL HEMIHYDRATE: 1 mg/1
- NORETHINDRONE ACETATE: .5 mg/1
- RELUGOLIX: 40 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72974-415"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72974-415
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc3feb73-cc84-43a8-aa32-b262460495e8